tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Scinai Immunotherapeutics Ltd

SCNI
Add to Watchlist
0.238USD
+0.008+3.30%
Market hours （ET）Quotes delayed by 15 min
824.05KMarket Cap
LossP/E TTM

Scinai Immunotherapeutics Ltd

0.238
+0.008+3.30%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

SCNI Financials

See Scinai Immunotherapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Scinai Immunotherapeutics Ltd Earnings Date

Latest Release
Jun 15, 2026
EPS / Forecast
0.96/--
Revenue / Forecast
489.00K/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
1.31M
99.24%
EPS(YoY)
-3.56
-159.73%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
Financial Indicators
EPS
--0.96
-97.78%-3.56
----
97.68%-1.80
-81.33%12.40
96.73%-3.64
60.52%-42.80
70.52%-77.60
-72.83%66.40
30.33%-111.20
---108.40
---263.20
--244.40
---159.60
----
----
----
----
----
----
----
----
----
----
Revenue
--489.00K
----
----
--206.00K
--168.00K
--284.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
--3.58M
----
----
4.29%-2.23M
236.50%10.46M
38.28%-2.32M
38.58%-2.16M
54.46%-2.33M
-34.97%3.11M
-26.11%-3.76M
-42.02%-3.52M
-50.09%-5.12M
270.73%4.78M
18.82%-2.98M
1.11%-2.48M
19.45%-3.41M
-117.29%-2.80M
69.24%-3.67M
-136.54%-2.50M
65.67%-4.23M
394.70%16.19M
9.46%-11.94M
----
----
Net Margin
--731.49%
41.47%-633.64%
----
---1082.52%
--6223.21%
---817.61%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
---228.63%
-149.53%-202.29%
----
---81.07%
---148.21%
---57.75%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
--1.63%
30.80%2.53%
-98.15%2.47%
-98.26%1.93%
-97.72%2.28%
14.01%133.46%
21.97%114.42%
--110.85%
--100.11%
--117.06%
--93.81%
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
--489.00K
----
----
--206.00K
--168.00K
--284.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
---2.47M
----
----
-25.62%-2.29M
-15.13%-2.42M
21.89%-2.03M
39.49%-1.93M
39.68%-1.82M
2.73%-2.10M
20.47%-2.59M
-21.84%-3.19M
12.89%-3.02M
15.07%-2.16M
-19.64%-3.26M
-26.62%-2.62M
4.74%-3.47M
-115.64%-2.54M
40.42%-2.73M
64.03%-2.07M
60.98%-3.64M
403.00%16.27M
16.49%-4.58M
----
----
Net Profit
--3.58M
----
----
4.29%-2.23M
236.50%10.46M
38.28%-2.32M
38.58%-2.16M
54.46%-2.33M
-34.97%3.11M
-26.11%-3.76M
-42.02%-3.52M
-50.09%-5.12M
270.73%4.78M
18.82%-2.98M
1.11%-2.48M
19.45%-3.41M
-117.29%-2.80M
69.24%-3.67M
-136.54%-2.50M
65.67%-4.23M
394.70%16.19M
9.46%-11.94M
----
----
Balance Sheet
Current assets
--3.61M
-14.09%2.05M
-58.82%1.51M
-56.10%2.39M
-75.91%1.62M
-52.93%3.66M
-52.43%5.25M
--5.45M
--6.71M
--7.77M
--11.04M
----
----
----
----
435.79%17.73M
38.30%11.20M
9.68%13.06M
18.30%14.70M
-84.38%3.31M
-63.53%8.10M
20.72%11.90M
-23.99%12.43M
2.96%21.18M
Total current liabilities
--2.69M
-12.24%1.58M
26.79%2.12M
1.46%1.81M
-9.49%1.39M
-11.44%1.67M
-25.36%1.93M
--1.78M
--1.54M
--1.89M
--2.58M
----
----
----
----
-88.39%2.32M
568.64%21.80M
1060.72%21.30M
1385.73%19.99M
264.05%19.99M
269.03%3.26M
-34.61%1.84M
-71.58%1.35M
-5.90%5.49M
Total assets
--17.59M
-13.55%11.63M
-20.27%11.84M
-23.03%13.45M
-34.02%12.26M
-25.36%14.85M
-26.79%17.05M
--17.47M
--18.58M
--19.90M
--23.29M
----
----
----
----
80.98%32.08M
14.80%25.14M
9.21%27.03M
14.54%28.39M
-47.13%17.73M
-36.26%21.90M
16.53%24.75M
-9.40%24.78M
18.33%33.53M
Total liabilities
--5.83M
1.50%3.52M
-82.01%3.98M
-84.25%3.47M
-89.39%2.26M
-18.05%22.14M
-21.12%22.17M
--22.04M
--21.27M
--27.01M
--28.10M
----
----
----
----
10.30%24.56M
6.25%23.84M
-39.60%23.54M
-42.33%22.15M
-53.68%22.27M
-37.81%22.43M
4.00%38.97M
20.93%38.41M
46.72%48.08M
Total equity
--11.76M
-18.78%8.10M
207.88%7.86M
318.36%9.98M
471.58%10.00M
-2.42%-7.28M
-6.36%-5.12M
---4.57M
---2.69M
---7.11M
---4.81M
----
----
----
----
265.32%7.52M
341.34%1.30M
124.58%3.50M
145.73%6.23M
68.76%-4.55M
68.74%-538.07K
12.39%-14.22M
-209.03%-13.63M
-228.03%-14.55M
Cash Flow Statement
Net operating income
---1.46M
----
----
12.16%-1.08M
8.28%-2.04M
38.87%-1.76M
52.17%-1.46M
-106.58%-1.23M
---2.22M
---2.88M
-176.83%-3.06M
71.32%-593.00K
----
----
6.46%-1.10M
56.69%-2.07M
36.57%-1.91M
28.06%-2.42M
88.03%-1.18M
2.28%-4.77M
57.34%-3.02M
44.62%-3.37M
-172.13%-9.87M
-186.40%-4.89M
Net investment
--2.75M
----
----
100.00%0.00
80.00%-4.00K
98.41%-6.00K
66.67%-2.00K
13.33%-234.00K
---20.00K
---377.00K
98.85%-6.00K
-232.71%-270.00K
----
----
-11460.46%-521.00K
-184.22%-81.15K
99.59%-4.02K
91.19%-32.78K
101.00%4.59K
133.93%96.35K
-59.76%-979.71K
-51.29%-371.91K
47.18%-458.44K
72.79%-283.95K
Net financing
--11.00K
----
----
--2.00M
-99.26%8.00K
--12.00K
--1.42M
-100.00%0.00
--1.09M
--0.00
--0.00
-21.60%6.78M
----
----
-100.00%0.00
9328.67%8.64M
-646.09%-305.65K
-103.40%-97.12K
980.19%12.79M
-102.10%-93.65K
-100.21%-40.97K
8175.47%2.86M
1474.37%1.18M
-50.86%4.46M

FAQs

What is the total revenue of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its total revenue reached 1.31M, with a year-on-year change of 658.00K.

What are the current assets of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its current assets were 2.05M, with a year-on-year change of -14.09.

What are the total assets of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its total assets of Scinai Immunotherapeutics Ltd were 11.63M, with a year-on-year change of -13.55.

What are the total liabilities of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its total liabilities of Scinai Immunotherapeutics Ltd were 3.52M, with a year-on-year change of 1.50.

What is the total equity of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its total equity of Scinai Immunotherapeutics Ltd was 8.10M, with a year-on-year change of -18.78.

What is the net operating income of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its net operating income of Scinai Immunotherapeutics Ltd was -7.54M, with a year-on-year change of 12.69.

What is the net investment of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its net investment of Scinai Immunotherapeutics Ltd was -24.00K, with a year-on-year change of -100.00.

What is the net financing of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its net financing of Scinai Immunotherapeutics Ltd was 5.77M, with a year-on-year change of 67.68.

What is the Earnings Per Share (EPS) of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -3.56, with a year-on-year change of -159.73.

What is the net income of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its net income was -8.31M, with a year-on-year change of -273.21.

What is the net margin of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its net profit margin was -633.64, with a year-on-year change of -186.93.

What is the gross margin of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its gross margin was -202.29, with a year-on-year change of -129.49.

What is the debt-to-asset ratio of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its debt-to-asset ratio was 2.53, with a year-on-year change of 30.80.

What is the Return on Assets (ROA) of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -66.26, with a year-on-year change of -313.59.

What is the operating profit of Scinai Immunotherapeutics Ltd?

According to Scinai Immunotherapeutics Ltd's FY2025 earnings report, its operating profit was -7.54M, with a year-on-year change of 12.69.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy